March 14, 2008
PES Drugs and Therapeutics Committee
In June of 2007, during the LWPES meeting in Toronto, the Drugs and Therapeutics Committee was informed of changes in the prescribing information for the different forms of rhGH. Each manufacturing company implemented changes specific to their product, but more importantly, a decision was made to harmonize all growth hormone product package inserts. This is the information provided in the insert for prescribers.